Nieves Martinez Lago/LinkedIn
Mar 11, 2025, 14:12
Nieves Martinez Lago: PEM in MSI and dMMR advanced solid tumors
Nieves Martinez Lago, Medical Oncologist at University Hospital Complex of Ferrol, shared an article by Aurelien Marabelle, et al. on X:
“PEM in MSI and dMMR advanced solid tumors: updated results KN-158 trial.
Phase II KN-158. N=373:
- ORR 33.8%.
- DoR 63.2 mo, OS 19.8 mo, PFS 4 mo.
- Grade ≥3 TRAEs: 13%.
Supports pembrolizumab use in MSI-H/dMMR solid tumors.”
Pembrolizumab in microsatellite-instability-high and mismatch-repair-deficient advanced solid tumors: updated results of the KEYNOTE-158 trial.
Authors: Aurelien Marabelle, et al.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 18, 2025, 20:22
Apr 18, 2025, 20:12
Apr 18, 2025, 20:03
Apr 18, 2025, 19:54
Apr 18, 2025, 19:49
Apr 18, 2025, 19:44
Apr 18, 2025, 19:26